Get In Touch

Enterobacteriaceae infections are caused by Enterobacter species, pathogens responsible for causing severe infections including bacteremia, urinary tract infections, lower respiratory tract infections, skin and soft tissue infections, and intra-abdominal infections. Signs and symptoms of Enterobacteriaceae infections include fever, hypotension and shock, septic shock, lower respiratory tract infections, etc. These infections need to be treated immediately with the usage of antimicrobial drugs. Major antibiotics involved to manage these infections include beta-lactams, carbapenems, amino-glycosides, fluoroquinolones, and TMP-SMZ. The choice of appropriate antibiotics is very important since many enterobacter species are resistant to antibiotics. A thorough understanding of anti-microbial resistance is important before prescribing the medication, since the genes that code resistance are mobile and can move between plasmids and also between different species and strains which are not resistance currently, but can become resistant in the future. The market drug resistance mediators include broad spectrum beta-lactamases, carbapenemases, extended-spectrum beta lactamases (ESBL), AmpC beta lactamases, modification of enzymes, alterated enzymes, decreased permeability, etc.

Rising prevalence of Enterobacteriaceae infectious diseases, increasing rate of new infections, and the continuous mutations in the microorganisms leading to new strains, are the driving factors driving the infectious diseases treatment market. Furthermore, increasing modes of transmission of the infectious disease and a lack of cleanliness in developing regions has fueled the infectious diseases market. However, asymptomatic conditions of infectious diseases, a lack of treatment for certain diseases, false positive results with certain tests are likely to hamper the expansion of tye infectious diseases testing market. The only restraining factor of the market is the rapid resistance to drugs currently available for enterobacter infections.

The global Enterobacteriaceae infections treatment market can be segmented based on antimicrobial drugs, distribution channel, and geography. Based on antimicrobial drug class, the market is segregated into beta-lactams, carbapenems, fluoroquinolones, aminoglycosides, and TMP-SMZ (Trimethoprim/Sulfamethoxazole). Beta-lactam drugs include penicillins, cephalosporins etc. Amongst these, cephalosporin drug class have good activity, while the activity of carbapenems is excellent. Tigecycline is the most recent drug class utilized in the treatment of Enterobacteriaceae infections. Recently, FDA approved meropenem/vaborbactam for complicated urinary tract infections resulting from carbapenem-resistant Enterobacteriaceae infections. In terms of distribution channel, the global Enterobacteriaceae infections treatment market can be segmented into hospital pharmacies, retail pharmacies, and online pharmacies. Hospital and retail pharmacies segments are witnessing rapid expansion due to the requirement of extended hospitalization due to these infections and also post-hospitalization course of treatment needs to be completed.

In terms of geography, the global Enterobacteriaceae infection treatment market is segregated into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The North America market is expected to expand during the forecast period, followed by Europe, due to the rise in demand for advanced treatment, rise in healthcare expenditure, and increased diagnosis rate. The market in Asia Pacific is likely to expand at a rapid rate due to the developing healthcare infrastructure, increased government expenditure, and higher number of patients in developing economies in the region.

Key market players operating in the Enterobacteriaceae infections treatment market include Genentech, Inc., Nanotherapeutics, Inc., Novartis AG, Pfizer Inc., Nymox Pharmaceutical Corporation, Sequoia Sciences, Inc., TheraCarb Inc., Phico Therapeutics Ltd., and Cantab Biopharmaceuticals Limited.

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.


Enterobacteriaceae Infections Treatment Market

Pre Book